{"store":{"baseInfo":{"podcastTitle":"שומרים - ערוץ התחקירים","slug":"shomrim","podcastDescription":"שומרים הוא גוף תקשורת ייחודי ששם לו למטרה לחזק את העיתונות החוקרת בישראל. \nהתחקירים שלנו מתפרסמים בכלי התקשורת המובילים בארץ ובעולם.","podcastLogo":"https://pbcdn1.podbean.com/imglogo/image-logo/17929965/_1__jpb4k3.jpg","podcastShareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/image-logo/17929965/_1__jpb4k3_1200x628.jpg?s=930d5ce4882d6a0c7587749e5323577d&e=jpg","podcastUrl":"https://shomrim.podbean.com","podcastCanSearched":true,"feedUrl":"https://feed.podbean.com/shomrim/feed.xml","theme":"playlist2","podcastDeepLink":"https://www.podbean.com/pw/pbblog-cwqir-11196ed?from=usersite","removePodbeanBranding":"no","brandingLogo":null,"timeZone":{"timeZoneId":42,"gmtAdjustment":"GMT+02:00","useDaylightTime":1,"value":2,"text":"(GMT+02:00) Jerusalem","daylightStartTime":"Second Sunday Of March +2 Hours","daylightEndTime":"First Sunday Of November +2 Hours","timezone":"Asia/Jerusalem"},"podcastDownloads":null,"totalEpisodes":73,"showComments":true,"iOSAppDownloadLink":null,"customizeCssUrl":null,"androidAppDownloadLink":null,"showPostShare":true,"showLike":true,"author":"Shomrim","enableEngagementStats":true,"shareEmbedLink":"https://admin5.podbean.com/embed.html?id=pbblog-cwqir-11196ed-playlist","language":"en","sensitivitySessionExpireTime":3600,"podcastApps":[{"name":"Apple Podcasts","link":"https://podcasts.apple.com/us/podcast/שומרים-ערוץ-התחקירים/id1734400005","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/apple-podcast.png","title":null},{"name":"YouTube","link":"https://www.youtube.com/playlist?list=PLt-Y1D9Yotw-DaiL6AUAS7Lsk3XR_NZH1","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/youtube_logo.png","title":null},{"name":"Podbean App","link":"https://www.podbean.com/pw/pbblog-cwqir-11196ed?from=usersite","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/podbean-app.png","title":null},{"name":"Spotify","link":"https://open.spotify.com/show/6cM6y8ZZ7XsrU7lI43j43H","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/spotify.png","title":null}],"components":{"base":[{"id":"MainStyle","val":"dark"},{"id":"Font","val":"Roboto"},{"id":"SecondaryFont","val":"Roboto"},{"id":"PlayerColor","val":"#C64747"},{"id":"PlayerStyle","val":"player2"},{"id":"PlayerWave","val":"show"},{"id":"Favicon","val":null},{"id":"CookiesNotice","val":"hide"},{"id":"CookiesNoticeContent","val":"

Cookies Notice

This website uses cookies to improve your experience while you navigate through the website. By using our website you agree to our use of cookies.

"}],"home-header":[{"id":"HomeHeaderTextColor","val":"#ffffff"},{"id":"BackgroundImage","val":"https://mcdn.podbean.com/mf/web/nj9hucwkechu6qw7/red-2.jpg"},{"id":"BackgroundImageForMobile","val":"https://mcdn.podbean.com/mf/web/xahfyzzwy5haizc4/red-3.jpg"}],"page-header":[{"id":"PageHeaderTextColor","val":"#ffffff"},{"id":"SecondaryPageBackgroundImage","val":"https://mcdn.podbean.com/mf/web/r88pvdcjpp3cem45/red-3_1_160fec41-7d11-59eb-61d8-50d4f53ff4c0.jpg"},{"id":"SecondaryPageBackgroundImageForMobile","val":"https://mcdn.podbean.com/mf/web/rqjfcwfms9v88ij7/red-33.jpg"}],"episode-list":[{"id":"EpisodeListType","val":"simple-list"},{"id":"EpisodesPerPage","val":10},{"id":"EpisodeStats","val":"show"}],"navigation":[{"id":"NavigationFontColor","val":"#ffffff"},{"id":"NavigationBackgroundColor","val":"#000000"},{"id":"NavigationSearch","val":"show"},{"id":"NavigationLinks","val":[{"id":"Home","type":"Link","value":"/","text":"Home","subitems":[]},{"id":"Subscribe","type":"Link","value":"https://www.podbean.com/site/podcatcher/index/blog/Ok6OKwia6uz2","text":"Subscribe","subitems":[]},{"id":"Profile","type":"Link","value":"https://www.podbean.com/user-zYEljLU85TV2","text":"Profile","subitems":[]}]}],"footer":[{"id":"FooterType","val":"Footer1"},{"id":"FooterFontColor","val":"#ffffff"},{"id":"FooterBackgroundColor","val":"#000000"},{"id":"FooterCopyright","val":"Copyright 2024 All rights reserved."},{"id":"SocialMediaLinks","val":{"facebook_username":"","twitter_username":"","instagram_username":"","youtube_username":"","linkedin_username":""}}],"customize-container1":[],"customize-container2":[]},"allLinks":[],"mainStylesDefaultSettings":null,"defaultCustomizeComponents":null,"scripts":[],"metas":null,"appConfig":{"package":"com.podbean.app.podcast","app_store_id":973361050,"app_name":"Podbean","scheme":"podbean"},"customizeCss":null,"canEditCss":null,"enableJsCodeInCustomizeContent":false,"enabledIframeCodeInCustomizeContent":true,"sectionMaxCount":10,"enableEditorLink":true,"enableEditCookiesNotice":true,"siteRedirectToFeed":false,"podcatcherRssUrl":null,"showFeed":true,"showTopBar":true,"enableWebSiteLike":true,"organizationName":null,"organizationPageLink":null},"backToListUrl":"/","tinymceLoaded":false,"listEpisodes":[],"userLikedEpisodes":[],"userLikeCheckedEpisodes":[],"topBarIframeLoaded":false,"listTotalCount":0,"listTotalPage":0,"listPage":0,"listType":"all","listValue":"","listName":"","pageLoading":false,"apiBaseUrl":"https://shomrim.podbean.com","apiCommonParams":{"t":"68441b23","clientSignature":"1de958447e15a7e644ec6172bb56b6d3","u":null,"customizing":null},"apiCommonHeaders":{},"comments":[],"commentsTotalCount":0,"commentsTotalPage":0,"commentsPage":1,"commentEpisodeId":"pb22917221-x6f5d","episode":{"id":"pb22917221","idTag":"x6f5d","title":"שאלת הגמילה","logo":"https://pbcdn1.podbean.com/imglogo/image-logo/17929965/_1__jpb4k3_300x300.jpg","shareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/image-logo/17929965/_1__jpb4k3_1200x628.jpg?s=930d5ce4882d6a0c7587749e5323577d&e=jpg","largeLogo":"https://pbcdn1.podbean.com/imglogo/image-logo/17929965/_1__jpb4k3.jpg","previewContent":null,"content":"

להיגמל מאופיואידים ביומיים ובלי קריז? אפשר, אבל לא בישראל.

פרק חדש בסדרת התחקירים של עיתונאי שומרים דניאל דולב בעקבות מגפת האופיואידים.

https://www.shomrim.news/hebrew/opioid-anr

הוקלט על ידי המרכז לתרבות מונגשת.

","publishTimestamp":1712840414,"duration":1525,"mediaUrl":"https://mcdn.podbean.com/mf/web/q878nbi7rdmbgymh/Shomrim-opioid-anr.mp3","mediaType":"audio/mpeg","shareLink":"https://admin5.podbean.com/embed.html?id=pb-x6f5d-15db065","likedCount":0,"deepLink":"https://www.podbean.com/ew/pb-x6f5d-15db065","transcriptUrl":null,"permalink":"/e/%d7%90%d7%a4%d7%a9%d7%a8-%d7%9c%d7%94%d7%99%d7%92%d7%9e%d7%9c/","downloadLink":"https://www.podbean.com/media/share/pb-x6f5d-15db065?download=1","fallbackResource":null,"fallbackResourceMimetype":null,"downloadCount":71,"status":"publish","hasMoreContent":false,"chaptersUrl":null,"explicit":false},"episodeShareLink":null,"deepLink":"https://www.podbean.com/ew/pb-x6f5d-15db065","playlist":{"episodes":[],"current":0,"start":0,"stop":0,"playing":true,"playerLoading":true,"playbackRate":1,"playbackRateIndex":1},"toasts":[],"confirm":null,"customizeEditorFormZIndex":999,"lastRequestTime":null,"validateChangesOnBeforeunload":true,"windowWidth":1000,"VITE_FS1_CDN_URL_PREFIX":"https://pbcdn1.podbean.com/fs1","reloadStats":false,"userIdEncrypted":null,"userProfilePicture":null,"username":null,"isVerified":false,"loadUserInfo":false,"loginUrl":"https://www.podbean.com/site/user/login?return=https%253A%252F%252Fshomrim.podbean.com%252Fe%252F%2525d7%252590%2525d7%2525a4%2525d7%2525a9%2525d7%2525a8-%2525d7%25259c%2525d7%252594%2525d7%252599%2525d7%252592%2525d7%25259e%2525d7%25259c%252F&rts=6569505984ff43a6076eca012038bf0a62e86689","recaptchaV3Loaded":false,"recaptchaV2Loaded":false,"likesLoaded":false,"commentLikeMap":{},"commentOffset":0},"episode":{"id":"pb22917221","idTag":"x6f5d","title":"שאלת הגמילה","logo":"https://pbcdn1.podbean.com/imglogo/image-logo/17929965/_1__jpb4k3_300x300.jpg","shareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/image-logo/17929965/_1__jpb4k3_1200x628.jpg?s=930d5ce4882d6a0c7587749e5323577d&e=jpg","largeLogo":"https://pbcdn1.podbean.com/imglogo/image-logo/17929965/_1__jpb4k3.jpg","previewContent":null,"content":"

להיגמל מאופיואידים ביומיים ובלי קריז? אפשר, אבל לא בישראל.

פרק חדש בסדרת התחקירים של עיתונאי שומרים דניאל דולב בעקבות מגפת האופיואידים.

https://www.shomrim.news/hebrew/opioid-anr

הוקלט על ידי המרכז לתרבות מונגשת.